AIP
DCPH

Almanack Investment Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Almanack Investment Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-180
Closed -$3K – 835
2022
Q3 		$3K Buy
+180
New +$2.83K ﹤0.01% 674

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Almanack Investment Partners's DCPH Position: Q4 2022 in Review

Almanack Investment Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 180 shares — an estimated $3K sold.

Almanack Investment Partners first reported a position in DCPH in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

  • Almanack Investment Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 180 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Almanack Investment Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.